Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD.

Arnaud D Kaze,Elisabetta Patorno,Julie M Paik

Current opinion in nephrology and hypertension（2023）

引用 0|浏览2

暂无评分

摘要

Although SGLT2i are associated with abnormalities of bone and mineral metabolism, they have not been linked to a higher risk of fracture among patients with CKD. More research is needed on the association between SGLT2i and fracture risk in this population.

查看译文

关键词

chronic kidney disease, fibroblast growth factor-23, phosphate, sodium-glucose cotransporter 2 inhibitors, vitamin D

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要